Cancer institute ties up with Novartis to aid poor patientsApril 13th, 2009 - 8:28 pm ICT by IANS
Coimbatore, April 13 (IANS) A premier cancer research institute distributed free dosages of an oncology drug here Monday under an arrangement with multinational pharmaceutical major Novartis.
“The first patient has been administered Glivec, an expensive drug that costs Rs.150,000 per month per patient, free-of-cost under an arrangement with Novartis. It’s part of the therapy of patients suffering from chronic myeloid leukaemia,” P. Guhan, director of Sri Ramakrishna Institute of Oncology Research (SRIOR), told reporters.
“The malignancy caused by the presence of philadelphia chromosome in the body is normally found in people in the 30-60 age group. Untreated, the malady claims its victim within 7 years, but the daily intake of a Glivec tablet will help patients live long reducing the disease’s effects,” Guhan added.
Under the auspices of ‘Glivec-Patient Assistance Programme,’ (G-PAP) SRIOR and Novartis have agreed to administer the drug freely to three patients. The numbers may go up later, a press statement issued by Sri Ramakrishna Hospital, which runs SRIOR, said.
The hospital was founded by the scions of S.N. Rangasamy Naidu, a local industrialist in 1970 in this textile town, 500 km southwest of Chennai with the primary objective of treating poor patients.
- SC again asks Novartis to cut cancer drug price - Sep 12, 2012
- Patents law provisions conflicting, Novartis tells SC - Sep 18, 2012
- Why don't you reduce cancer drug price, SC asks Novartis - Sep 11, 2012
- 'Chewing betel leaf may help fight cancer' - Sep 18, 2012
- Rangasamy sworn in, announces 25 kg free rice for poor - May 16, 2011
- Study links Blood pressure drugs to cancer - Jun 15, 2010
- Gene mutation behind onset of acute myeloid leukaemia identified - Mar 28, 2011
- Vaccination can prevent cervical cancer deaths: Experts - Aug 07, 2012
- Antibiotic dosing guidelines to help counteract superbugs - Jul 05, 2011
- Leukaemia vaccine goes on clinical trial - Feb 01, 2011
- Targeted cancer drug more effective after first-line treatment - Feb 28, 2011
- New drug may fight ovarian cancer - Jun 07, 2010
- New drug shows promise in treating Fragile X - Jan 08, 2011
- Two units of umbilical cord blood 'reduce leukemia recurrence risk' - Nov 14, 2009
- One dead in stampede during 'fish prasadam' distribution (Lead) - Jun 08, 2012
Tags: age group, auspices, cancer institute, cancer research institute, chennai, industrialist, malady, malignancy, myeloid leukaemia, novartis, oncology, oncology drug, oncology research, pap, patient assistance, philadelphia chromosome, poor patients, scions, sri ramakrishna, textile town